SAN DIEGO, Feb. 21, 2018 /PRNewswire/ — Evofem Biosciences, Inc., (NASDAQ: EVFM) ("Evofem" or the "Company"), a biotechnology company developing innovative products to fill women's unmet healthcare needs, today announced that the U.S. Food and Drug…Original Article
Evofem Biosciences Receives Fast Track Designation for Amphora for Prevention of Chlamydia
